Literature DB >> 12226156

Surgery and the reduction of mortality from prostate cancer.

Patrick C Walsh.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12226156     DOI： 10.1056/NEJMe020089

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  [New concept minimizes bleeding in radical retropubic prostatectomy].

Authors:  M Schostak; K Matischak; M Schäfer; M Müller; M Schrader; F Christoph; K Miller
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

2.  A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.

Authors:  Baris Turkbey; Harsh K Agarwal; Joanna Shih; Marcelino Bernardo; Yolanda L McKinney; Dagane Daar; Gary L Griffiths; Sandeep Sankineni; Linda Johnson; Kinzya B Grant; Juanita Weaver; Soroush Rais-Bahrami; Mukesh Harisinghani; Paula Jacobs; William Dahut; Maria J Merino; Peter A Pinto; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

3.  Clinical features of prostate cancer before diagnosis: a population-based, case-control study.

Authors:  William Hamilton; Deborah J Sharp; Tim J Peters; Alison P Round
Journal:  Br J Gen Pract       Date:  2006-10       Impact factor: 5.386

Review 4.  Cancer diagnosis in primary care.

Authors:  William Hamilton
Journal:  Br J Gen Pract       Date:  2010-02       Impact factor: 5.386

5.  Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in patients with recurrent prostate cancer.

Authors:  Diana V Kouiavskaia; Carla A Berard; Ellen Datena; Arif Hussain; Nancy Dawson; Elena N Klyushnenkova; Richard B Alexander
Journal:  J Immunother       Date:  2009 Jul-Aug       Impact factor: 4.456

6.  The value of appropriate assessment prior to specialist referral in men with prostatic symptoms.

Authors:  M R Quinlan; B J O'Daly; M F O'Brien; S Gardner; G Lennon; D W Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

Review 7.  Prostate cancer management: (1) an update on localised disease.

Authors:  S R J Bott; A J Birtle; C J Taylor; R S Kirby
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 8.  Symptomatic diagnosis of prostate cancer in primary care: a structured review.

Authors:  William Hamilton; Deborah Sharp
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

9.  Tissue-scale, personalized modeling and simulation of prostate cancer growth.

Authors:  Guillermo Lorenzo; Michael A Scott; Kevin Tew; Thomas J R Hughes; Yongjie Jessica Zhang; Lei Liu; Guillermo Vilanova; Hector Gomez
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

10.  Nomogram to predict insignificant prostate cancer at radical prostatectomy in Korean men: a multi-center study.

Authors:  Jae Seung Chung; Han Yong Choi; Hae-Ryoung Song; Seok-Soo Byun; Seong Il Seo; Cheryn Song; Jin Seon Cho; Sang Eun Lee; Hanjong Ahn; Eun Sik Lee; Tae-Kon Hwang; Wun-Jae Kim; Moon Kee Chung; Tae Young Jung; Ho Song Yu; Young Deuk Choi
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.